Neuronetics Financial Statements From 2010 to 2026

STIM Stock  USD 1.90  0.09  4.97%   
Neuronetics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Neuronetics' valuation are provided below:
Gross Profit
66.1 M
Profit Margin
(0.34)
Market Capitalization
130.1 M
Enterprise Value Revenue
1.484
Revenue
129.9 M
There are over one hundred nineteen available fundamental ratios for Neuronetics, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to check Neuronetics' last-minute fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road.

Neuronetics Total Revenue

61.86 Million

Check Neuronetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuronetics' main balance sheet or income statement drivers, such as Interest Income of 3.3 M, Depreciation And Amortization of 1.3 M or Interest Expense of 4.4 M, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0 or PTB Ratio of 1.89. Neuronetics financial statements analysis is a perfect complement when working with Neuronetics Valuation or Volatility modules.
  
Build AI portfolio with Neuronetics Stock
Check out the analysis of Neuronetics Correlation against competitors.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

Neuronetics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets106.9 M162 M76 M
Slightly volatile
Short and Long Term Debt Total49.8 M95 M39.8 M
Slightly volatile
Other Current Liabilities10.1 M15.9 M8.5 M
Slightly volatile
Total Current Liabilities22 M36 M18.7 M
Slightly volatile
Other Liabilities1.2 M746.1 K906 K
Slightly volatile
Property Plant And Equipment Net40.3 M38.3 M8.8 M
Slightly volatile
Current Deferred Revenue1.5 M876.6 K1.6 M
Pretty Stable
Accounts Payable13.4 M12.7 M4.3 M
Slightly volatile
Cash21.3 M22.4 M39.1 M
Slightly volatile
Non Current Assets Total100 M95.2 M22.8 M
Slightly volatile
Non Currrent Assets Other8.8 M12.8 M5.6 M
Slightly volatile
Other Assets1.091.1511.6 M
Pretty Stable
Long Term Debt37 M63.4 M29.2 M
Slightly volatile
Cash And Short Term Investments21.5 M22.6 M39.6 M
Slightly volatile
Net Receivables29.3 M27.9 M10 M
Slightly volatile
Common Stock Total Equity329.6 K313.9 K135.6 K
Slightly volatile
Common Stock Shares Outstanding19.4 M36.5 M12.6 M
Slightly volatile
Long Term Debt Total28.2 M26.3 M22 M
Slightly volatile
Liabilities And Stockholders Equity106.9 M162 M76 M
Slightly volatile
Non Current Liabilities Total63.2 M70.1 M116.2 M
Slightly volatile
Capital Surpluse238.9 M463.1 M190.3 M
Slightly volatile
InventoryM4.9 M3.6 M
Slightly volatile
Other Current Assets12 M11.4 M3.7 M
Slightly volatile
Other Stockholder Equity312.6 M514 M201 M
Slightly volatile
Total Liabilities79.3 M98.2 M134.2 M
Slightly volatile
Property Plant And Equipment Gross44.2 M42.1 M9.6 M
Slightly volatile
Short and Long Term Debt16.1 M15.1 M10.6 M
Slightly volatile
Preferred Stock Total Equity197.7 M215.2 M183.3 M
Slightly volatile
Total Current Assets84.8 M66.8 M57.8 M
Slightly volatile
Short Term Debt6.7 M4.3 M6.8 M
Very volatile
Common Stock672.6 K640.5 K192.2 K
Slightly volatile
Property Plant Equipment2.7 M2.3 M2.1 M
Slightly volatile
Net Working Capital23 M24.2 M42.7 M
Slightly volatile
Intangible Assets23.7 M22.5 M4.9 M
Slightly volatile
Deferred Long Term Liabilities905.7 K953.4 K2.1 M
Pretty Stable
Capital Stock672.6 K640.5 K274.6 K
Slightly volatile
Short Term Investments176.1 K185.4 K935 K
Pretty Stable
Capital Lease Obligations33.2 M31.6 M8.2 M
Slightly volatile
Long Term Investments73.5 K77.4 K1.3 M
Slightly volatile
Non Current Liabilities Other3.2 M3.4 M2.8 M
Slightly volatile

Neuronetics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income3.3 M4.2 M2.9 M
Slightly volatile
Depreciation And Amortization1.3 M2.4 M1.1 M
Slightly volatile
Interest Expense4.4 M8.4 M3.5 M
Slightly volatile
Selling General Administrative21 M34.9 M15.8 M
Slightly volatile
Selling And Marketing Expenses42.1 M52.5 M33.5 M
Slightly volatile
Total Revenue61.9 M86.1 M50.6 M
Slightly volatile
Gross Profit46.8 M62.3 M38.7 M
Slightly volatile
Other Operating Expenses88.7 M125.9 M70.7 M
Slightly volatile
Research Development10.6 M14.7 M9.5 M
Slightly volatile
Cost Of Revenue15.1 M23.8 M11.9 M
Slightly volatile
Total Operating Expenses73.7 M102 M58.8 M
Slightly volatile
Reconciled Depreciation1.4 M2.4 M1.1 M
Slightly volatile

Neuronetics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock254.8 K268.2 K6.9 M
Very volatile
Stock Based Compensation4.9 M6.4 M3.1 M
Slightly volatile
Begin Period Cash Flow63.6 M68.6 M45.8 M
Slightly volatile
Depreciation1.3 M2.4 M1.1 M
Slightly volatile
Other Non Cash Items14.3 M13.6 M3.1 M
Slightly volatile
Capital Expenditures1.6 M1.7 M1.1 M
Slightly volatile
End Period Cash Flow21.3 M22.4 M39.1 M
Slightly volatile
Change To Netincome10.6 M10.1 M4.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.580.610.9908
Slightly volatile
Days Sales Outstanding11210758.3806
Slightly volatile
Stock Based Compensation To Revenue0.05760.06730.0471
Slightly volatile
Capex To Depreciation0.910.640.8643
Slightly volatile
EV To Sales1.141.370.9384
Slightly volatile
Inventory Turnover3.965.613.8468
Very volatile
Days Of Inventory On Hand96.1967.32106
Pretty Stable
Payables Turnover4.052.153.8878
Slightly volatile
Sales General And Administrative To Revenue0.260.360.2806
Slightly volatile
Research And Ddevelopement To Revenue0.20.17050.2018
Slightly volatile
Capex To Revenue0.01930.01760.0183
Slightly volatile
Cash Per Share0.680.71780
Slightly volatile
Days Payables Outstanding88.06176103
Slightly volatile
Income Quality0.70.640.8111
Pretty Stable
Intangibles To Total Assets0.260.240.1305
Slightly volatile
Current Ratio2.032.143.0932
Slightly volatile
Receivables Turnover3.373.557.5347
Slightly volatile
Capex Per Share0.05050.053115.0425
Slightly volatile
Revenue Per Share2.582.711.5 K
Slightly volatile
Interest Debt Per Share3.13.26977
Slightly volatile
Debt To Assets0.540.670.617
Slightly volatile
Operating Cycle145174161
Slightly volatile
Days Of Payables Outstanding88.06176103
Slightly volatile
Ebt Per Ebit1.261.461.1936
Very volatile
Effective Tax Rate6.0E-44.0E-47.0E-4
Slightly volatile
Quick Ratio1.881.982.9057
Slightly volatile
Net Income Per E B T1.11.151.015
Slightly volatile
Cash Ratio0.680.722.2674
Pretty Stable
Days Of Inventory Outstanding96.1967.32106
Pretty Stable
Days Of Sales Outstanding11210758.3806
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.850.941.0307
Slightly volatile
Fixed Asset Turnover2.452.5816.7746
Slightly volatile
Debt Ratio0.540.670.617
Slightly volatile
Price Sales Ratio0.580.610.9908
Slightly volatile
Asset Turnover0.760.610.9335
Slightly volatile
Gross Profit Margin0.840.830.786
Slightly volatile

Neuronetics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap249.4 K280.5 K306.2 K
Slightly volatile
Enterprise Value787.4 K828.8 K1.8 M
Slightly volatile

Neuronetics Fundamental Market Drivers

Neuronetics Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Neuronetics Financial Statements

Neuronetics investors utilize fundamental indicators, such as revenue or net income, to predict how Neuronetics Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue876.6 K1.5 M
Total Revenue86.1 M61.9 M
Cost Of Revenue23.8 M15.1 M
Stock Based Compensation To Revenue 0.07  0.06 
Sales General And Administrative To Revenue 0.36  0.26 
Research And Ddevelopement To Revenue 0.17  0.20 
Capex To Revenue 0.02  0.02 
Revenue Per Share 2.71  2.58 
Ebit Per Revenue(0.53)(0.56)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:
Check out the analysis of Neuronetics Correlation against competitors.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.83)
Revenue Per Share
2.238
Quarterly Revenue Growth
1.013
Return On Assets
(0.21)
Return On Equity
(2.19)
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.